SEC Form 4 · accession 0001104659-16-122649
Aralez Pharmaceuticals Inc. · ARLZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Patrick Tursi
Officer — Chief Medical Officer
Period of report
May 20, 2016
Accepted (ET)
May 23, 2016 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001660719
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, without par value | May 20, 2016 | P | 10,000 | $3.75 | A | 179,368 | D |
Table II — derivative securities
No Table II lines on this filing.